Chronic moderate sleep restriction in older long sleepers and older average duration sleepers: a randomized controlled trial.

TitleChronic moderate sleep restriction in older long sleepers and older average duration sleepers: a randomized controlled trial.
Publication TypeJournal Article
Year of Publication2013
AuthorsYoungstedt SD, Jean-Louis G, Bootzin RR, Kripke DF, Cooper J, Dean LR, Catao F, James S, Vining C, Williams NJ, Irwin MR
JournalContemp Clin Trials
Volume36
Issue1
Pagination175-86
Date Published2013 Sep
ISSN1559-2030
KeywordsActigraphy, Age Factors, Aged, Aged, 80 and over, Aging, Chronic Disease, Cognition, Depression, Disorders of Excessive Somnolence, Female, Glucose Tolerance Test, Health Behavior, Health Status, Humans, Lipids, Male, Middle Aged, Quality of Life, Research Design, Sleep, Sleep Wake Disorders, Time Factors
Abstract

Epidemiologic studies have consistently shown that sleeping <7 h and ≥8 h is associated with increased mortality and morbidity. The risks of short sleep may be consistent with results from experimental sleep deprivation studies. However, there has been little study of chronic moderate sleep restriction and little evaluation of older adults who might be more vulnerable to negative effects of sleep restriction, given their age-related morbidities. Moreover, the risks of long sleep have scarcely been examined experimentally. Moderate sleep restriction might benefit older long sleepers who often spend excessive time in bed (TIB) in contrast to older adults with average sleep patterns. Our aims are: (1) to examine the ability of older long sleepers and older average sleepers to adhere to 60 min TIB restriction; and (2) to contrast effects of chronic TIB restriction in older long vs. average sleepers. Older adults (n = 100) (60-80 years) who sleep 8-9 h per night and 100 older adults who sleep 6-7.25 h per night will be examined at 4 sites over 5 years. Following a 2-week baseline, participants will be randomized to one of two 12-week treatments: (1) a sleep restriction involving a fixed sleep-wake schedule, in which TIB is reduced 60 min below each participant's baseline TIB; and (2) a control treatment involving no sleep restriction, but a fixed sleep schedule. Sleep will be assessed with actigraphy and a diary. Measures will include glucose tolerance, sleepiness, depressive symptoms, quality of life, cognitive performance, incidence of illness or accident, and inflammation.

DOI10.1016/j.cct.2013.06.014
Alternate JournalContemp Clin Trials
PubMed ID23811325
PubMed Central IDPMC3860282
Grant ListP30 AG028748 / AG / NIA NIH HHS / United States
P30-AG028748 / AG / NIA NIH HHS / United States
R01 CA160245-01 / CA / NCI NIH HHS / United States
R01 DA032922-01 / DA / NIDA NIH HHS / United States
R01 HL095799 / HL / NHLBI NIH HHS / United States
R01 HL095799 / HL / NHLBI NIH HHS / United States
R01 MD004113 / MD / NIMHD NIH HHS / United States
R01-AG026364 / AG / NIA NIH HHS / United States
R01-AG034588 / AG / NIA NIH HHS / United States
R01-CA119159 / CA / NCI NIH HHS / United States
R01MD004113 / MD / NIMHD NIH HHS / United States
R25 GM076277 / GM / NIGMS NIH HHS / United States
R25 HL105444 / HL / NHLBI NIH HHS / United States
R25HL105444 / HL / NHLBI NIH HHS / United States
UL1TR000124 / TR / NCATS NIH HHS / United States